Showing results (601-610 of 687) with videos related to

Sort By:
Pageof 69
Cancer Research|October 2, 2010
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic deathRoberta Zappasodi, Serenella M Pupa, Gaia C Ghedini, et al.
Cell Reports|September 30, 2016
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell ActivitySabina Sangaletti, Claudio Tripodo, Alessandra Santangelo, et al.
Stem Cells (Dayton, Ohio)|August 16, 2005
Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cellsMichela Aluigi, Miriam Fogli, Antonio Curti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing miceVincenzo Bronte, Paolo Serafini, Carmela De Santo, et al.
Molecular Cancer Therapeutics|December 17, 2016
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-βElena Jachetti, Alice Rigoni, Lucia Bongiovanni, et al.
Pigment Cell & Melanoma Research|June 30, 2011
Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanomaGianfranco Mattia, M Cristina Errico, Federica Felicetti, et al.
Haematologica|November 14, 2000
Antitumor vaccination: where we standM Bocchia, V Bronte, M P Colombo, et al.
Journal of Neurosurgery|March 4, 2000
Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in ratsF DiMeco, L D Rhines, J Hanes, et al.
The Journal of Clinical Investigation|April 17, 2003
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomasClaudia Curcio, Emma Di Carlo, Raphael Clynes, et al.
Pageof 69